General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Details Narrative)

v3.10.0.1
Stockholders' Equity (Details Narrative) - USD ($)
 3 Months Ended
Mar. 19, 2018
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Dec. 31, 2016
Number of shares acquired in exchange for common stock   2,090,301    
Common stock issued   35,272,626   35,272,626 31,745,242
Common stock shares outstanding   35,272,626   35,272,626 31,745,242
Recognization of license intangible asset   8,000,000      
Additional Paid-In Capital [Member]          
Recognization of license intangible asset   8,000,000      
CoNCERT Pharmaceuticals, Inc [Member]          
Option exercised in exchange for common stock $ 8,000,000        
Number of shares acquired in exchange for common stock 2,090,301        
Common stock, per share $ 3.83        
Percentage of common stock holdings 6.58%        
Precentage of issued and outstanding common stock diluted basis 5.93%        
Common stock issued 35,272,626        
Common stock shares outstanding 35,272,626        
Controlling interest, description Promet’s controlling interest was reduced from 90% to 84%.        
CoNCERT Pharmaceuticals, Inc [Member] | Additional Paid-In Capital [Member]          
Recognization of license intangible asset   8,000,000